Illumina, Inc. (ILMN) Financials

ILMN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 10.1 billion 4.4 billion
2023-09-30 10.1 billion 4.2 billion
2023-06-30 11.8 billion 5.2 billion
2023-03-31 11.8 billion 5.1 billion

ILMN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 172.0 million 94.0 million
2023-09-30 94.0 million 87.0 million
2023-06-30 58.0 million 106.0 million
2023-03-31 -42.0 million 93.0 million

ILMN Net Income

No data available :(

ILMN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.1 billion - 773.0 million
2023-09-30 933.0 million 1.5 billion 698.0 million
2023-06-30 1.6 billion 1.5 billion 726.0 million
2023-03-31 1.5 billion 1.5 billion 747.0 million

ILMN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 159.0 million
2023-09-30 158.0 million
2023-06-30 158.0 million
2023-03-31 158.0 million

ILMN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 51.0 million 329.0 million 485.0 million -
2023-09-30 45.0 million 315.0 million 303.0 million -
2023-06-30 47.0 million 358.0 million 450.0 million -
2023-03-31 52.0 million 341.0 million 378.0 million -

ILMN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 1.1 billion 447.0 million
2023-09-30 1.1 billion 435.0 million
2023-06-30 1.2 billion 444.0 million
2023-03-31 1.1 billion 432.0 million

ILMN

Price: $117.93

52 week price:
89.00
232.88

Payout Ratio Range:
23.10%
34.42%

Earnings Per Share: -7.35 USD

P/E Ratio: -20.31

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 1.1 million

Ebitda: 273.0 million

Market Capitalization: 19.8 billion

Links: